Psychiatry - Neuro/Psych Pharmacol News & Articles

681 The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone Drug and Alcohol Dependence, May 30, 2012    Clinical Article

682 Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry European Archives of Psychiatry and Clinical Neuroscience, May 30, 2012    Clinical Article

683 Effects of medication on neuroimaging findings in bipolar disorder: an updated review Bipolar Disorders, May 30, 2012    Clinical Article

684 Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes Full Text BMC Psychiatry, May 25, 2012    Clinical Article

685 A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD Journal of Attention Disorders, May 25, 2012    Clinical Article

686 Does Stimulant Pretreatment Modify Atomoxetine Effects on Core Symptoms of ADHD in Children Assessed by Quantitative Measurement Technology Journal of Attention Disorders, May 25, 2012    Clinical Article

687 Patient satisfaction with methadone maintenance treatment: The relevance of participation in treatment and social functioning Drug and Alcohol Dependence, May 24, 2012    Clinical Article

688 Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis : The Lancet The Lancet - Early Online Publication, May 23, 2012    Evidence Based Medicine    Clinical Article

689 Update on the development of lurasidone as a treatment for patients with acute schizophrenia Full Text Drug Design, Development and Therapy, May 23, 2012    Clinical Article

690 Cost Effectiveness of Quetiapine in Patients with Acute Bipolar Depression and in Maintenance Treatment after an Acute Depressive Episode PharmacoEconomics, May 23, 2012    Clinical Article

691 High dose methylphenidate treatment in adult Attention Deficit Hyperactivity Disorder: a case report Full Text Journal of Medical Case Reports, May 23, 2012    Clinical Article

692 Sustained-Release Bupropion for Smoking Cessation in a Chinese Sample: A Double-Blind, Placebo-Controlled Randomized Trial Nicotine & Tobacco Research, May 23, 2012    Clinical Article

693 Atypical Antipsychotic Drugs, Schizophrenia, and Metabolic Syndrome in Non-Euro-American Societies Clinical Neuropharmacology, May 22, 2012    Clinical Article

694 Antidepressant Use and Risk of Out-of-Hospital Cardiac Arrest: A Nationwide Case–Time–Control Study Clinical Pharmacology & Therapeutics, May 22, 2012    Clinical Article

695 A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder International Journal of Neuropsychopharmacology, May 22, 2012    Clinical Article

696 Does olanzapine inhibit the psychomimetic effects of {Delta}9-tetrahydrocannabinol Journal of Psychopharmacology, May 22, 2012    Clinical Article

697 Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal - a case series Journal of Psychopharmacology, May 22, 2012    Clinical Article

698 Sibutramine-induced mania as the first manifestation of bipolar disorder. Full Text BMC Psychiatry, May 22, 2012    Clinical Article

699 Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine Journal of Psychopharmacology, May 22, 2012    Clinical Article

700 Early Non-Response in Patients with Severe Depression: Escitalopram Up-Titration versus Switch to Duloxetine Clinical Drug Investigation, May 21, 2012    Clinical Article

1 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013    Evidence Based Medicine

2 Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013    Evidence Based Medicine

3 Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia International Clinical Psychopharmacology, April 25, 2013

4 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013    Free full text

5 Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study Schizophrenia Research, April 16, 2013

6 A randomized add-on trial of high-dose d -cycloserine for treatment-resistant depression International Journal of Neuropsychopharmacology, March 6, 2013

7 Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies Journal of Psychopharmacology, April 8, 2013

8 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013

9 Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials European Archives of Psychiatry and Clinical Neuroscience, April 22, 2013    Evidence Based Medicine

10 A Randomized Trial on the Acute and Steady-State Effects of a New Antidepressant, Vortioxetine, on Actual Driving and Cognition Clinical Pharmacology & Therapeutics, April 24, 2013

11 Guidance for the Discontinuation or Switching of Antidepressant Therapies in Adults Journal of Pharmacy Practice, March 26, 2013    Clinical Guideline

12 The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial Schizophrenia Research, April 17, 2013

13 A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence European Neuropsychopharmacology, April 12, 2013

14 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 5, 2013

15 Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression Human Psychopharmacology: Clinical and Experimental, March 28, 2013

16 Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only Journal of Psychiatric Research, April 15, 2013

17 Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial International Journal of Neuropsychopharmacology, April 2, 2013
Exclusive Author Commentary

18 Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis Neuropsychiatric Disease and Treatment, April 9, 2013    Free full text

19 The Fetal Safety of Fluoxetine: A Systematic Review and Meta-Analysis Journal of Obstetrics and Gynaecology Canada, April 11, 2013    Free full text    Evidence Based Medicine    Review Article

20 A double-blind, placebo-controlled study of adjunctive calcitonin nasal spray in acute refractory mania Bipolar Disorders, April 2, 2013